1
|
Treppo E, Monti S, Delvino P, Marvisi C, Ricordi C, La Rocca G, Moretti M, Italiano N, Di Cianni F, Ferro F, Muratore F, Baldini C, Talarico R, Quartuccio L, Salvarani C. Systemic vasculitis: one year in review 2024. Clin Exp Rheumatol 2024; 42:771-781. [PMID: 38683204 DOI: 10.55563/clinexprheumatol/gkve60] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2024] [Accepted: 04/16/2024] [Indexed: 05/01/2024]
Abstract
Systemic vasculitides comprise a collection of rare and heterogeneous disorders capable of impacting any organ and system, posing a considerable burden of mortality and comorbidity. As with previous annual reviews of this series, this review will offer a critical overview of the latest literature on pathogenesis, biomarkers, and treatment options in both small- and large-vessel vasculitis.
Collapse
Affiliation(s)
- Elena Treppo
- Clinic of Rheumatology, Department of Medicine, University of Udine, Hospital Santa Maria della Misericordia, Udine, Italy.
| | - Sara Monti
- Department of Internal Medicine and Therapeutics, University of Pavia, and Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
| | - Paolo Delvino
- School of Medicine, University of Milano Bicocca, Milan, and IRCCS San Gerardo dei Tintori Foundation, Monza, Italy
| | - Chiara Marvisi
- Rheumatology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, and Università di Modena e Reggio Emilia, Modena, Italy
| | - Caterina Ricordi
- Rheumatology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, and Università di Modena e Reggio Emilia, Modena, Italy
| | - Gaetano La Rocca
- Rheumatology Unit, Azienda Ospedaliero-Universitaria Pisana, University of Pisa, Italy
| | - Michele Moretti
- Rheumatology Unit, Azienda Ospedaliero-Universitaria Pisana, University of Pisa, Italy
| | - Nazzareno Italiano
- Rheumatology Unit, Azienda Ospedaliero-Universitaria Pisana, University of Pisa, Italy
| | - Federica Di Cianni
- Rheumatology Unit, Azienda Ospedaliero-Universitaria Pisana, University of Pisa, Italy
| | - Francesco Ferro
- Rheumatology Unit, Azienda Ospedaliero-Universitaria Pisana, University of Pisa, Italy
| | - Francesco Muratore
- Rheumatology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, and Università di Modena e Reggio Emilia, Modena, Italy
| | - Chiara Baldini
- Rheumatology Unit, Azienda Ospedaliero-Universitaria Pisana, University of Pisa, Italy
| | - Rosaria Talarico
- Rheumatology Unit, Azienda Ospedaliero-Universitaria Pisana, University of Pisa, Italy
| | - Luca Quartuccio
- Clinic of Rheumatology, Department of Medicine, University of Udine, Hospital Santa Maria della Misericordia, Udine, Italy
| | - Carlo Salvarani
- Rheumatology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, and Università di Modena e Reggio Emilia, Modena, Italy
| |
Collapse
|
2
|
Moretti M, Treppo E, Monti S, La Rocca G, Del Frate G, Delvino P, Italiano N, Di Cianni F, D'Alessandro F, Talarico R, Ferro F, Quartuccio L, Baldini C. Systemic vasculitis: one year in review 2023. Clin Exp Rheumatol 2023; 41:765-773. [PMID: 37073639 DOI: 10.55563/clinexprheumatol/zf4daj] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2023] [Accepted: 04/13/2023] [Indexed: 04/20/2023]
Abstract
Systemic vasculitides are heterogeneous disabling diseases characterised by chronic inflammation of the blood vessels potentially leading to tissue destruction and organ failure. The recent COVID-19 pandemic has had a significant impact on the epidemiology and management of patients with systemic vasculitis. In parallel, new insights have been provided on systemic vasculitis pathogenetic mechanisms, possible new therapeutic targets, and newer glucocorticoid-sparing treatments with better safety profiles. As in the previous annual reviews of this series, in this review we will provide a critical digest of the most recent literature regarding pathophysiology, clinical manifestations, diagnostic tools and treatment options in small- and large-vessel vasculitis focusing on precision medicine in vasculitis.
Collapse
Affiliation(s)
- Michele Moretti
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy
| | - Elena Treppo
- Clinic of Rheumatology, Department of Medical and Biological Sciences, University Hospital Santa Maria della Misericordia, Udine, Italy
| | - Sara Monti
- Department of Rheumatology, University of Pavia, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy
| | - Gaetano La Rocca
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy
| | - Giulia Del Frate
- Clinic of Rheumatology, Department of Medical and Biological Sciences, University Hospital Santa Maria della Misericordia, Udine, Italy
| | - Paolo Delvino
- Department of Rheumatology, University of Pavia, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy
| | - Nazzareno Italiano
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy
| | - Federica Di Cianni
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy
| | - Francesco D'Alessandro
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy
| | - Rosaria Talarico
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy
| | - Francesco Ferro
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy
| | - Luca Quartuccio
- Clinic of Rheumatology, Department of Medical and Biological Sciences, University Hospital Santa Maria della Misericordia, Udine, Italy
| | - Chiara Baldini
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
| |
Collapse
|
3
|
Cardelli C, Caruso T, Tani C, Pratesi F, Talarico R, Di Cianni F, Italiano N, Laurino E, Moretti M, Cascarano G, Diomedi M, Gualtieri L, D'Urzo R, Migliorini P, Mosca M. COVID-19 mRNA vaccine booster in patients with autoimmune rheumatic diseases. Rheumatology (Oxford) 2022; 61:e328-e330. [PMID: 35608304 PMCID: PMC9384146 DOI: 10.1093/rheumatology/keac296] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2022] [Revised: 05/04/2022] [Accepted: 05/11/2022] [Indexed: 11/13/2022] Open
Affiliation(s)
- Chiara Cardelli
- Department of Clinical and Experimental Medicine, University of Pisa
- Rheumatology Unit
| | - Teresita Caruso
- Department of Clinical and Experimental Medicine, University of Pisa
- Immunoallergology Unit, Azienda Ospedaliero-Universitaria Pisana
| | | | - Federico Pratesi
- Department of Clinical and Experimental Medicine, University of Pisa
- Department of Translational Research and NTMS, University of Pisa, Pisa, Italy
| | | | - Federica Di Cianni
- Department of Clinical and Experimental Medicine, University of Pisa
- Rheumatology Unit
| | - Nazzareno Italiano
- Department of Clinical and Experimental Medicine, University of Pisa
- Rheumatology Unit
| | - Elenia Laurino
- Department of Clinical and Experimental Medicine, University of Pisa
- Rheumatology Unit
| | - Michele Moretti
- Department of Clinical and Experimental Medicine, University of Pisa
- Rheumatology Unit
| | - Giancarlo Cascarano
- Department of Clinical and Experimental Medicine, University of Pisa
- Rheumatology Unit
| | - Michele Diomedi
- Department of Clinical and Experimental Medicine, University of Pisa
- Rheumatology Unit
| | - Luca Gualtieri
- Department of Clinical and Experimental Medicine, University of Pisa
- Rheumatology Unit
| | | | - Paola Migliorini
- Department of Clinical and Experimental Medicine, University of Pisa
- Immunoallergology Unit, Azienda Ospedaliero-Universitaria Pisana
| | - Marta Mosca
- Department of Clinical and Experimental Medicine, University of Pisa
- Rheumatology Unit
| |
Collapse
|
4
|
Bandeira M, Di Cianni F, Marinello D, Arnaud L, Cannizzo S, Carta C, Cornet A, Barril SM, Bulina I, Ferraris A, Fonseca J, Gaglioti A, Limper M, Lorenzoni V, Majnik J, Matucci-Cerinic M, Palla I, Rednic S, Schneider M, Smith V, Sulli A, Søndergaard K, Ticciati S, Tincani A, Turchetti G, Talarico R, Cutolo M, Mosca M, Taruscio D. An overlook on the current registries for rare and complex connective tissue diseases and the future scenario of TogethERN ReCONNET. Front Med (Lausanne) 2022; 9:889997. [PMID: 36226147 PMCID: PMC9549150 DOI: 10.3389/fmed.2022.889997] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2022] [Accepted: 08/25/2022] [Indexed: 11/17/2022] Open
Abstract
Background Patient registries play a crucial role in supporting clinical practice, healthcare planning and medical research, offering a real-world picture on rare and complex connective tissue diseases (rCTDs). ERN ReCONNET launched the first European Registry Infrastructure with the aim to plan, upgrade and link registries for rCTDs, with the final goal to promote a harmonized data collection approach all over Europe for rCTDs. Methods An online survey addressed to healthcare professionals and patients' representatives active in the field of rCTDs was integrated by an extensive database search in order to build a mapping of existing registries for rCTDs. Findings A total of 140 registries were found, 38 of which include multiple diseases. No disease-specific registry was identified for relapsing polychondritis, mixed connective tissue disease and undifferentiated connective tissue disease. Discussion This overview on the existing registries for rCTDs provides a useful starting point to identify the gaps and the strengths of registries on the coverage of rCTDs, and to develop a common data set and data collection approach for the establishment of the TogethERN ReCONNET Infrastructure.
Collapse
Affiliation(s)
- Matilde Bandeira
- Rheumatology Department, Lisbon Academic Medical Centre, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal
- Rheumatology Research Unit, Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal
| | - Federica Di Cianni
- Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana, University of Pisa, Pisa, Italy
| | - Diana Marinello
- Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana, University of Pisa, Pisa, Italy
| | - Laurent Arnaud
- Rheumatology Department, Hôpitaux Universitaires de Strasbourg, Centre National de Référence des Maladies Systémiques et Auto-immunes Rares Grand-Est Sud-Ouest, Strasbourg, France
| | - Sara Cannizzo
- Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana, University of Pisa, Pisa, Italy
- Institute of Management, Sant'Anna School of Advanced Studies, Pisa, Italy
| | - Claudio Carta
- National Centre for Rare Diseases, Istituto Superiore di Sanità, Rome, Italy
| | | | - Sara M. Barril
- Rheumatology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain
| | - Inita Bulina
- Department of Rheumatology, Stradins Clinical University Hospital, Riga, Latvia
| | - Alessandro Ferraris
- Medical Genetics Laboratory, Molecular Medicine Department, San Camillo Forlanini Hospital, Sapienza University, Rome, Italy
| | - João Fonseca
- Rheumatology Department, Lisbon Academic Medical Centre, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal
- Rheumatology Research Unit, Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal
| | - Andrea Gaglioti
- Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana, University of Pisa, Pisa, Italy
| | - Marteen Limper
- Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands
| | | | - Judith Majnik
- Department of Rheumatology and Clinical Immunology, Semmelweis University, Budapest, Hungary
| | - Marco Matucci-Cerinic
- Division of Rheumatology and Scleroderma Unit, Department of Clinical and Experimental Medicine, Azienda Ospedaliero Universitaria (AOU) Careggi, University of Florence, Florence, Italy
- Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Milan, Italy
- Department of Rheumatology, Emergency County Teaching Hospital, University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania
| | - Ilaria Palla
- Institute of Management, Sant'Anna School of Advanced Studies, Pisa, Italy
| | - Simona Rednic
- Department of Rheumatology, Emergency County Teaching Hospital, University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania
| | - Matthias Schneider
- Department of Rheumatology, University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany
| | - Vanessa Smith
- Department of Rheumatology, Department of Internal Medicine, Ghent University Hospital, Ghent, Belgium
- Unit for Molecular Immunology and Inflammation, VIB Inflammation Research Centre, Ghent, Belgium
| | - Alberto Sulli
- Laboratory of Experimental Rheumatology, Division of Clinical Rheumatology, Department of Internal Medicine (DIMI), University of Genoa, Genoa, Italy
- IRCCS Polyclinic Hospital San Martino, Genoa, Italy
| | - Klaus Søndergaard
- Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark
| | - Simone Ticciati
- Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana, University of Pisa, Pisa, Italy
| | - Angela Tincani
- Rheumatology and Clinical Immunology Unit, ASST-Spedali Civili, University of Brescia, Brescia, Italy
| | - Giuseppe Turchetti
- Institute of Management, Sant'Anna School of Advanced Studies, Pisa, Italy
| | - Rosaria Talarico
- Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana, University of Pisa, Pisa, Italy
- *Correspondence: Rosaria Talarico
| | - Maurizio Cutolo
- Laboratory of Experimental Rheumatology, Division of Clinical Rheumatology, Department of Internal Medicine (DIMI), University of Genoa, Genoa, Italy
- IRCCS Polyclinic Hospital San Martino, Genoa, Italy
| | - Marta Mosca
- Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana, University of Pisa, Pisa, Italy
| | - Domenica Taruscio
- National Centre for Rare Diseases, Istituto Superiore di Sanità, Rome, Italy
| |
Collapse
|
5
|
Mastrolia MV, Marinello D, Di Cianni F, Talarico R, Simonini G. Assessing quality of life in Behçet's disease: a systematic review. Clin Exp Rheumatol 2022; 40:1560-1566. [DOI: 10.55563/clinexprheumatol/sian1b] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2022] [Accepted: 05/26/2022] [Indexed: 11/13/2022]
Affiliation(s)
| | - Diana Marinello
- Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy
| | - Federica Di Cianni
- Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy
| | - Rosaria Talarico
- Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy
| | - Gabriele Simonini
- Rheumatology Unit, Meyer Children’s University Hospital, NEUROFARBA Department, University of Florence, Italy
| |
Collapse
|
6
|
La Rocca G, Del Frate G, Delvino P, Di Cianni F, Moretti M, Nazzareno I, Treppo E, Monti S, Talarico R, Ferro F, Quartuccio L, Baldini C. Systemic vasculitis: one year in review 2022. Clin Exp Rheumatol 2022; 40:673-687. [DOI: 10.55563/clinexprheumatol/ozhc85] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/11/2022] [Accepted: 04/27/2022] [Indexed: 11/13/2022]
Affiliation(s)
- Gaetano La Rocca
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy
| | - Giulia Del Frate
- Clinic of Rheumatology, Department of Medical and Biological Sciences, University Hospital Santa Maria della Misericordia, Udine, Italy
| | - Paolo Delvino
- Department of Rheumatology, University of Pavia, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy
| | - Federica Di Cianni
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy
| | - Michele Moretti
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy
| | - Italiano Nazzareno
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy
| | - Elena Treppo
- Clinic of Rheumatology, Department of Medical and Biological Sciences, University Hospital Santa Maria della Misericordia, Udine, Italy
| | - Sara Monti
- Department of Rheumatology, University of Pavia, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy
| | - Rosaria Talarico
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy
| | - Francesco Ferro
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
| | - Luca Quartuccio
- Clinic of Rheumatology, Department of Medical and Biological Sciences, University Hospital Santa Maria della Misericordia, Udine, Italy
| | - Chiara Baldini
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy
| |
Collapse
|
7
|
Marinello D, Di Cianni F, Del Bianco A, Mattioli I, Sota J, Cantarini L, Emmi G, Leccese P, Lopalco G, Mosca M, Padula A, Piga M, Salvarani C, Taruscio D, Talarico R. Empowering Patients in the Therapeutic Decision-Making Process: A Glance Into Behçet's Syndrome. Front Med (Lausanne) 2021; 8:769870. [PMID: 34966756 PMCID: PMC8710680 DOI: 10.3389/fmed.2021.769870] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2021] [Accepted: 11/18/2021] [Indexed: 12/03/2022] Open
Abstract
Behçet's syndrome (BS) represents a challenging condition, characterized by a variable spectrum of disease profile and associated with a significant limitation of the daily activities as well as a potential negative impact on relationships and psychological status. Considering also the complexity of the therapeutic management of BS, that often includes biological off-label treatments, the participation in the therapeutic decision-making process of the BS patients is essential to ensure the integration of the care process into the life of the patient. For this reason, the empowerment of BS patients represents a crucial need and the present work is aimed at fully exploring all the potential variables implicated in the BS patient empowerment, also highlighting major points to consider and concrete actions to be planned in the immediate future in order to implement a pragmatic facilitation of the patients' empowerment.
Collapse
Affiliation(s)
- Diana Marinello
- Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana, University of Pisa, Pisa, Italy
| | - Federica Di Cianni
- Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana, University of Pisa, Pisa, Italy
| | | | - Irene Mattioli
- Department of Experimental and Clinical Medicine, University of Firenze, Firenze, Italy
| | - Jurgen Sota
- Rheumatology Unit, Department of Medicine, Surgery, and Neurosciences, University of Siena, Siena, Italy
| | - Luca Cantarini
- Rheumatology Unit, Department of Medicine, Surgery, and Neurosciences, University of Siena, Siena, Italy
| | - Giacomo Emmi
- Department of Experimental and Clinical Medicine, University of Firenze, Firenze, Italy
| | - Pietro Leccese
- Rheumatology Department of Lucania, Rheumatology Institute of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera, Potenza and Matera, Italy
| | - Giuseppe Lopalco
- Rheumatology Unit, Department of Emergence Medicine and Transplantation (DETO), University of Bari Aldo Moro, Bari, Italy
| | - Marta Mosca
- Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana, University of Pisa, Pisa, Italy
| | - Angela Padula
- Rheumatology Department of Lucania, Rheumatology Institute of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera, Potenza and Matera, Italy
| | - Matteo Piga
- Rheumatology Unit, Department of Medical Sciences and Public Health, AOU University Clinic and University of Cagliari, Cagliari, Italy
| | - Carlo Salvarani
- Rheumatology Unit, Azienda USL-IRCCS di Reggio Emilia and Università di Modena e Reggio Emilia, Modena, Italy
| | - Domenica Taruscio
- National Centre for Rare Diseases, Istituto Superiore di Sanità, Rome, Italy
| | - Rosaria Talarico
- Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana, University of Pisa, Pisa, Italy
| |
Collapse
|
8
|
Tani C, Pratesi F, Talarico R, Cardelli C, Caruso T, Di Cianni F, Laurino E, Italiano N, Moretti M, Manca ML, Migliorini P, Mosca M. Efficacy of anti-SARS-CoV-2 mRNA vaccine in systemic autoimmune disorders: induction of high avidity and neutralising anti-RBD antibodies. RMD Open 2021; 7:e001914. [PMID: 34880126 PMCID: PMC8655339 DOI: 10.1136/rmdopen-2021-001914] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/03/2021] [Accepted: 11/01/2021] [Indexed: 12/18/2022] Open
Abstract
OBJECTIVES In patients with systemic autoimmune rheumatic disorders (SARDs), vaccination with SARS-CoV-2 mRNA vaccines has been proposed. The aim of this study is to evaluate the immune response elicited by vaccination with mRNA vaccine, testing IgM, IgA and IgG antibodies to SARS-CoV-2 receptor-binding domain (RBD) and measuring neutralising antibodies. METHODS IgG, IgM and IgA anti-RBD antibodies were measured in 101 patients with SARDs. Antibodies inhibiting the interaction between RBD and ACE2 were evaluated. Antibody avidity was tested in a chaotropic ELISA using urea. Twenty-one healthcare workers vaccinated with mRNA vaccine served as control group. RESULTS Anti-RBD IgG and IgA were produced after the first dose (69% and 64% of the patients) and after the boost (93% and 83%). Antibodies inhibiting the interaction of RBD with ACE2 were detectable in 40% of the patients after the first dose and 87% after boost, compared with 100% in healthy controls (p<0.01). Abatacept and mycophenolate had an impact on the titre of IgG anti-RBD antibodies (p<0.05 and p<0.005, respectively) and on the amount of neutralising antibodies. No effect of other therapies was observed. Vaccinated patients produce high avidity antibodies, as healthy controls. CONCLUSIONS These data show that double-dose vaccination induced in patients with SARDs anti-RBD IgG and IgA antibodies in amounts not significantly different from controls, and, most interestingly, characterised by high avidity and endowed with neutralising activity.
Collapse
Affiliation(s)
- Chiara Tani
- Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy
| | - Federico Pratesi
- Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
- Immunoallergology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy
| | - Rosaria Talarico
- Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy
| | - Chiara Cardelli
- Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy
- Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
| | - Teresita Caruso
- Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
- Immunoallergology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy
| | - Federica Di Cianni
- Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy
- Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
| | - Elenia Laurino
- Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy
- Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
| | - Nazzareno Italiano
- Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy
- Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
| | - Michele Moretti
- Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy
- Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
| | - Maria Laura Manca
- Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
- Immunoallergology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy
| | - Paola Migliorini
- Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
- Immunoallergology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy
| | - Marta Mosca
- Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy
- Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
| |
Collapse
|
9
|
Ferro F, Quartuccio L, Monti S, Delvino P, Di Cianni F, Fonzetti S, La Rocca G, Posarelli C, Treppo E, talarico R, Baldini C. One year in review 2021: systemic vasculitis. Clin Exp Rheumatol 2021; 39 Suppl 129:3-12. [DOI: 10.55563/clinexprheumatol/v1tpfo] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2021] [Accepted: 05/04/2021] [Indexed: 11/13/2022]
Affiliation(s)
- Francesco Ferro
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
| | - Luca Quartuccio
- Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital Santa Maria della Misericordia, Udine, Italy
| | - Sara Monti
- Department of Rheumatology, University of Pavia, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy
| | - Paolo Delvino
- Department of Rheumatology, University of Pavia, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy
| | - Federica Di Cianni
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy
| | - Silvia Fonzetti
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy
| | - Gaetano La Rocca
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy
| | - Chiara Posarelli
- Ophthalmology Unit, Department of Surgical, Medical, Molecular Pathology and Emergency, University of Pisa, Italy
| | - Elena Treppo
- Clinic of Rheumatology, Department of Medical and Biological Sciences, University Hospital Santa Maria della Misericordia, Udine, Italy
| | - Rosaria talarico
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy
| | - Chiara Baldini
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy
| |
Collapse
|